Asthika Goonewardene
Stock Analyst at Truist Securities
(2.97)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RVMD Revolution Medicines | Initiates Coverage On: Buy | 99 | 41.06 | 141.11% | 1 | Sep 5, 2025 | |
MRSN Mersana Therapeutics | Maintains: Buy | 250 36 | 7.04 | 411.36% | 5 | Aug 14, 2025 | |
GILD Gilead Sciences | Upgrades: Buy | 108 127 | 115.88 | 9.6% | 2 | Aug 8, 2025 | |
EXEL Exelixis | Maintains: Buy | 56 49 | 37.69 | 30.01% | 11 | Jul 29, 2025 | |
GMAB Genmab | Maintains: Strong Buy | 45 46 | 27.54 | 67.03% | 15 | Jul 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 2 1 | 1.27 | -21.26% | 9 | Jun 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 151 155 | 102.66 | 50.98% | 3 | Jun 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 88 71 | 34.62 | 105.08% | 2 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 10 | 1.14 | 777.19% | 7 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | 1.43 | 599.3% | 4 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 15 | 2.38 | 530.25% | 6 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 32 7 | 4.47 | 56.6% | 3 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 19.45 | 79.95% | 1 | Jan 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 87 136 | 71.11 | 91.25% | 5 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 0.98 | 1430.61% | 6 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 44 | 11.44 | 284.62% | 1 | Jun 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 69 88 | 67.19 | 30.97% | 2 | Jun 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 4 | 1.45 | 175.86% | 5 | May 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 19 | 1.81 | 949.72% | 3 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 229 | 228.74 | 0.11% | 4 | Oct 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 | n/a | n/a | 4 | Sep 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 27 | 0.76 | 3452.63% | 2 | Sep 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 15 18 | 31.23 | -42.36% | 2 | Jun 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Hold | 120 | 25.77 | 365.66% | 1 | Apr 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 8 3 | 1.48 | 102.7% | 3 | Mar 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | 23.01 | -13.08% | 3 | Dec 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 100 60 | 2.11 | 2743.6% | 3 | Aug 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 228 180 | 4.91 | 3565.99% | 4 | Aug 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 55 96 | n/a | n/a | 2 | Mar 3, 2020 |